Cara Therapeutics | CARA - 应收帐款人





应收帐款人 更改 日
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
Alterity Therapeutics Limited AUD 8.67M 1.59M 2023-06
Assertio Holdings USD 39.91M 2.7M 2024-06
Cara Therapeutics USD 2.24M 2.26M 2025-03
Cassava Sciences USD 120K 697K 2025-12
Chugai Pharma JPY 443.11B 89.26B 2025-12
Cipla INR 74.61B 19.39B 2025-09
Clal Biotechnology ILS 3.75M 186K 2022-12
Compugen USD 2.38M 448K 2025-12
CSL USD 4.32B 1.35B 2025-12
Grifols EUR 1B 285.88M 2025-12
Halozyme Therapeutics USD 441.27M 95.24M 2025-12
J&J USD 17.61B 235M 2025-09
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Pacira USD 124.07M 8.8M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
RedHill Biopharma USD 5.35M 1.78M 2025-06
Supernus Pharmaceuticals USD 187.8M 16.55M 2025-12
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12